Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ionis
Pharma
Ionis' Tryngolza win in sHTG sends shares soaring by 27%
Ionis has hit a “home run,” according to Citi, with data that show the ability of Tryngolza to treat severe hypertriglyceridemia.
Kevin Dunleavy
Sep 2, 2025 11:30am
Ionis, Arrowhead sponsor new triglyceride education group
Mar 28, 2025 10:10am
Tryngolza's FDA approval marks 'pivotal moment' for Ionis: CEO
Dec 20, 2024 8:32am
Inside #FierceMadness winner Wainua's 'phonetic appeal'
Apr 15, 2024 4:16pm
FDA awards Biogen's ALS drug Qalsody an accelerated approval
Apr 25, 2023 2:28pm
AstraZeneca targets Pfizer and Alnylam with Ionis ATTR pact
Dec 7, 2021 11:24am
